Table 5.
Immune Cell Subset | Neutrophils | Monocytes | |||||
---|---|---|---|---|---|---|---|
Coefficient | 95% CI | p Value | Coefficient | 95% CI | p Value | ||
Sex | Male | Reference | - | - | Reference | - | - |
Female | −0.0 ± 0.5 | −1.0 to 0.9 | 0.98 | −0.0 ± 0.1 | −0.1 to 0.1 | 0.53 | |
Age, years | - | - | 0.25 | - | - | 0.53 | |
<55 | Reference | - | - | Reference | - | - | |
55–64 | −0.1 ± 0.8 | −1.8 to 1.5 | - | −0.0 ± 0.1 | −0.2 to 0.1 | - | |
65–74 | 0.1 ± 0.8 | −1.5 to 1.6 | - | 0.0 ± 0.1 | −0.1 to 0.2 | - | |
75–84 | −0.1 ± 0.8 | −1.7 to 1.5 | - | −0.0 ± 0.1 | −0.2 to 0.1 | - | |
>84 | 1.2 ± 1.0 | −0.8 to 3.2 | - | −0.1 ± 0.1 | −0.3 to 0.1 | - | |
Disease modality (TIA vs. AIS) | 1.5 ± 0.5 | 0.5 to 2.5 | 0.005 | 0.1 ± 0.1 | 0.0 to 0.2 | 0.04 | |
National Institutes of Health Stroke Scale | - | - | 0.031 | - | - | 0.72 | |
0–4 | Reference | - | - | Reference | - | - | |
5–9 | 1.0 ± 0.7 | −0.4 to 2.5 | - | 0.0 ± 0.1 | −0.1 to 0.2 | - | |
10–15 | 1.0 ± 0.8 | −0.7 to 2.6 | - | 0.0 ± 0.1 | −0.1 to 0.2 | - | |
>15 | 1.8 ± 1.0 | −0.2 to 3.7 | - | 0.0 ± 0.1 | −0.2 to 0.2 | - | |
Thrombolysis | 0.0 ± 0.6 | −1.2 to 1.3 | 0.96 | −0.0 ± 0.1 | −0.1 to 0.1 | 0.88 | |
Use of platelet inhibitor before blood taking | 2.4 ± 1.2 | 0.1 to 4.7 | 0.46 | −0.0 ± 0.1 | −0.1 to 0.1 | 0.58 |
AIS, acute ischemic stroke; CI, confidence interval; TIA, transient ischemic stroke.